A Microsoft-led team demonstrated that generative AI models can redesign toxic proteins to evade current DNA synthesis biosecurity screening software, raising concerns about dual-use risks. While the study was digital-only and proactive warnings have led to patches, the evolving nature of AI protein design underscores the necessity for ongoing vigilance and innovation in safeguarding biotechnology against potential misuse.